InsiderTradesSIGMA

PicksTOP Companies Executives Performance Blog Topics

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FRUSDEGBCHCAITESNLBENOSEFIDKAUATIEBRINJP+ 8 markets

Recommendations
Companies
Insiders
Performance
Backtest
Compare

Markets
Sectors
Top movers
Leaderboard
Clusters
Heatmap
Earnings radar
Archive

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 28 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

Theme: dark (range regime detected on CAC40 90d · as of 2026-05-26)

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

All systems operational

InsidersTradesSigma

US US6,790 companies

US-Listed Companies

Regulator: SEC (Form 4).

Priority Income Fund, Inc.

Finance & Banque

Priority Technology Holdings, Inc.

Priority Technology Holdings, Inc.

Finance & Banque

Privacore VPC Asset Backed Credit Fund

Finance & Banque

Privia Health Group, Inc.

Santé & Pharma · 2.9bn

ProCap Financial, Inc.

Finance & Banque · 163m

ProFrac Holding Corp.

Énergie · 704m

ProMIS Neurosciences Inc.

Santé & Pharma · 93m

ProPetro Holding Corp.

Énergie · 992m

ProPhase Labs, Inc.

Santé & Pharma · 521k

← PreviousPage 100 of 136Next →

ProSight Global, Inc.

Assurance

Proassurance CORP

Assurance · 1.2bn

Procaccianti Hotel Reit, INC.

Tourisme & Hôtellerie

Processa Pharmaceuticals, Inc.

Santé & Pharma · 6.5m

Procore Technologies, INC.

Services aux entreprises · 7bn

Professional Diversity Network, Inc.

Services aux entreprises · 8.3m

Professional Holding Corp.

Finance & Banque

Proficient Auto Logistics, Inc

Transport & Logistique · 268m

Profire Energy INC

Progenity, INC.

Santé & Pharma

Progress Software CORP /ma

Technologie · 1.2bn

Progressive CORP

Assurance · 133bn

Progressive Care Inc.

Santé & Pharma

Santé & Pharma · 2.2bn

Prokidney CORP.

Santé & Pharma · 501m

Prometheus Biosciences, Inc.

Santé & Pharma

Propanc Biopharma, Inc.

Santé & Pharma · 59k

Property Solutions Acquisition Corp. II

Prospect Capital CORP

Finance & Banque

Prosperity Bancshares INC

Finance & Banque · 6.4bn

Protagenic Therapeutics, Inc.\new

Santé & Pharma · 1.2m

Protagonist Therapeutics, Inc

Santé & Pharma · 5.5bn

Protalix BioTherapeutics, Inc.

Santé & Pharma · 160m

Protara Therapeutics, Inc.

Santé & Pharma · 286m

Protective Insurance Corp

Transport & Logistique

Prothena CORP Public Ltd Co

Santé & Pharma · 514m

Industrie · 1.2bn

ProtoKinetix, Inc.

Santé & Pharma · 2.1m

Provention Bio, Inc.

Santé & Pharma

Provident Bancorp, Inc.

Finance & Banque

Provident Financial Holdings INC

Finance & Banque · 103m

Provident Financial Services INC

Finance & Banque · 2.6bn

Prudential Financial INC

Assurance · 39bn

Psychemedics CORP

Santé & Pharma · 15m

Médias & Communication · 416m

Public Service Enterprise Group INC

Énergie · 38bn